Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.
Georgia Tech and Emory University researchers have developed an innovative new technology that will help pediatric cardiac surgeons design and test a customized surgical procedure before they ever pick up a scalpel.
Johns Hopkins engineers are trying to help surgeons by adding such “touch” sensations, known as haptic feedback, to medical robotic systems.
A new type of stethoscope enables doctors to hear the sounds of the body in extremely loud situations, such as during the transportation of wounded soldiers in Blackhawk helicopters.
An implantable pump can help heart-failure patients live and recover strength while they wait for a transplant. But an evaluation concludes that the UK’s National Health Service should continue to restrict the technology’s use — at least for now.
Scientists now understand how an important protein converts chemical energy to mechanical force, thus powering the process of cell division, thanks to a new structural model by University of North Carolina at Chapel Hill researchers.
People who experience their first-ever bout of depression after having a heart attack are at greater risk for future heart problems than are patients who either don?t become clinically depressed after the medical emergency or who were depressed even before the incident, new research shows.
The first large-scale review of weight-loss surgeries performed on older adults suggests bariatric procedures should generally be limited to people younger than age 65, researchers at UT Southwestern Medical Center have found.
The turbidity of red wine during its ageing in oak casks has an influence on the accumulation of volatile compounds and, thereby, on the wine’s aroma, but not on the accumulation of biogenic amines. This is the conclusion of Nerea Jim?nez Moreno in her PhD thesis defended at the Public University of Navarre.
Breast cancer sufferers could eventually benefit from high-tuned, tailor-made drug treatments that minimize side effects as a result of a joint initiative between computer scientists in Edinburgh and cellular biologists in Japan.